Evidence map›Paper›PMID 39338299›Full record

ReviewPharmaceuticals (Basel, Switzerland)2024

A Comprehensive Review of Silver and Gold Nanoparticles as Effective Antibacterial Agents.

Ricardo Aguilar-Garay, Luis F Lara-Ortiz, Maximiliano Campos-López, Dafne E Gonzalez-Rodriguez, Margoth M Gamboa-Lugo, Jorge A Mendoza-Pérez, Álvaro Anzueto-Ríos, Dulce E Nicolás-Álvarez

Abstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Biosynthesis and Characterization ofNanomaterials (Basel, Switzerland) · 2026
    Article
  12. Biogenesis ofInternational journal of molecular sciences · 2026
    Article
  13. Article
  14. Article
  15. Nanosystems for delivery of indolicidin peptide.Frontiers in medical technology · 2026
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ricardo Aguilar-GarayClean Technologies, Environmental Process Development and Green Engineering Laboratory, Department of Environmental Systems Engineering, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 07738, Mexico.ORCID 0000-0002-3566-1330
Luis F Lara-OrtizHormones and Behavior Laboratory, Department of Physiology, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 07738, Mexico.ORCID 0009-0003-8832-4586
Maximiliano Campos-LópezClean Technologies, Environmental Process Development and Green Engineering Laboratory, Department of Environmental Systems Engineering, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 07738, Mexico.
Dafne E Gonzalez-RodriguezClean Technologies, Environmental Process Development and Green Engineering Laboratory, Department of Environmental Systems Engineering, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 07738, Mexico.
Margoth M Gamboa-LugoFaculty of Chemical and Biological Sciences, Universidad Autónoma de Sinaloa, Culiacan 80013, Mexico.ORCID 0009-0000-4277-1821
Jorge A Mendoza-PérezClean Technologies, Environmental Process Development and Green Engineering Laboratory, Department of Environmental Systems Engineering, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 07738, Mexico.ORCID 0000-0002-8651-3506
Álvaro Anzueto-RíosBionic Academy, Unidad Profesional Interdisciplinaria en Ingeniería y Tecnologías Avanzadas, Instituto Politécnico Nacional, Mexico City 07340, Mexico.ORCID 0000-0003-1627-0323
Dulce E Nicolás-ÁlvarezHormones and Behavior Laboratory, Department of Physiology, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 07738, Mexico.ORCID 0000-0002-1717-9081

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing threat from antibiotic-resistant bacteria has necessitated the development of novel methods to counter bacterial infections. In this context, the application of metallic nanoparticles (NPs), especially gold (Au) and silver (Ag), has emerged as a promising strategy due to their remarkable antibacterial properties. This review examines research published between 2006 and 2023, focusing on leading journals in nanotechnology, materials science, and biomedical research. The primary applications explored are the efficacy of Ag and Au NPs as antibacterial agents, their synthesis methods, morphological properties, and mechanisms of action. An extensive review of the literature on NPs synthesis, morphology, minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and effectiveness against various Gram(+/-) bacteria confirms the antibacterial efficacy of Au and Ag NPs. The synthesis methods and characteristics of NPs, such as size, shape, and surface charge, are crucial in determining their antibacterial activity, as these factors influence their interactions with bacterial cells. Furthermore, this review underscores the urgent necessity of standardizing synthesis techniques, MICs, and reporting protocols to enhance the comparability and reproducibility of future studies. Standardization is essential for ensuring the reliability of research findings and accelerating the clinical application of NP-based antimicrobial approaches. This review aims to propel NP-based antimicrobial strategies by elucidating the properties that enhance the antibacterial activity of Ag and Au NPs. By highlighting their inhibitory effects against various bacterial strains and relatively low cytotoxicity, this work positions Ag and Au NPs as promising materials for developing antibacterial agents, making a significant contribution to global efforts to combat antibiotic-resistant pathogens.

Indexed as

Ag nanoparticlesantibacterial propertiesantibiotic resistanceAu nanoparticlesbacterial infectionsminimum bactericidal concentration (MBC)minimum inhibitory concentration (MIC)nanoparticle synthesisnanotechnology

Identifiers

PMID39338299
PMCPMC11434858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.